Find Clinical Trial

Efficacy and safety assessment of two schemes of oral administration of once-daily extended release metformin (metformin XR) in type 2 diabetic patients previously treated with metformin in combination with sulfonylurea. A 3-month, international, multicentre, randomised, double-blind, double-dummy, parallel group study.


← Back
Study Phase

Phase 2

Therapeutic Area

Metabolism

Active substance/
Medical device

METFORMINE, S005720, GLICLAZIDE

SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS005720
Protocol CodeCL2-05720-005
EudraCT Code2011-006054-82


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility